Recombinant Human Torsin-1A (TOR1A)

Code CSB-YP024067HU
Size Pls inquire
Source Yeast
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-EP024067HU
Size Pls inquire
Source E.coli
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-EP024067HU-B
Size Pls inquire
Source E.coli
Conjugate Avi-tag Biotinylated
E. coli biotin ligase (BirA) is highly specific in covalently attaching biotin to the 15 amino acid AviTag peptide. This recombinant protein was biotinylated in vivo by AviTag-BirA technology, which method is BriA catalyzes amide linkage between the biotin and the specific lysine of the AviTag.
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-BP024067HU
Size Pls inquire
Source Baculovirus
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-MP024067HU
Size Pls inquire
Source Mammalian cell
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Purity
>85% (SDS-PAGE)
Target Names
TOR1A
Uniprot No.
Alternative Names
DQ2; Dystonia 1; Dystonia 1 protein; Dystonia 1 torsion; Dyt1; TOR1A; TOR1A_HUMAN; Torsin 1A; Torsin A; Torsin family 1 member A; Torsin family 1, member A (torsin A); Torsin-1A
Species
Homo sapiens (Human)
Expression Region
21-332
Target Protein Sequence
VEPISLGLAL AGVLTGYIYP RLYCLFAECC GQKRSLSREA LQKDLDDNLF GQHLAKKIIL NAVFGFINNP KPKKPLTLSL HGWTGTGKNF VSKIIAENIY EGGLNSDYVH LFVATLHFPH ASNITLYKDQ LQLWIRGNVS ACARSIFIFD EMDKMHAGLI DAIKPFLDYY DLVDGVSYQK AMFIFLSNAG AERITDVALD FWRSGKQRED IKLKDIEHAL SVSVFNNKNS GFWHSSLIDR NLIDYFVPFL PLEYKHLKMC IRVEMQSRGY EIDEDIVSRV AEEMTFFPKE ERVFSDKGCK TVFTKLDYYY DD
Protein Length
Full Length of Mature Protein
Tag Info
Tag type will be determined during the manufacturing process.
The tag type will be determined during production process. If you have specified tag type, please tell us and we will develop the specified tag preferentially.
Form
Lyophilized powder
Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand.
Buffer before Lyophilization
Tris/PBS-based buffer, 6% Trehalose, pH 8.0
Reconstitution
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
Troubleshooting and FAQs
Storage Condition
Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
Shelf Life
The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Lead Time
Delivery time may differ from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Note: All of our proteins are default shipped with normal blue ice packs, if you request to ship with dry ice, please communicate with us in advance and extra fees will be charged.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Datasheet
Please contact us to get it.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Protein with chaperone functions important for the control of protein folding, processing, stability and localization as well as for the reduction of misfolded protein aggregates. Involved in the regulation of synaptic vesicle recycling, controls STON2 protein stability in collaboration with the COP9 signalosome complex (CSN). In the nucleus, may link the cytoskeleton with the nuclear envelope, this mechanism seems to be crucial for the control of nuclear polarity, cell movement and, specifically in neurons, nuclear envelope integrity. Participates in the cellular trafficking and may regulate the subcellular location of multipass membrane proteins such as the dopamine transporter SLC6A3, leading to the modulation of dopamine neurotransmission. In the endoplasmic reticulum, plays a role in the quality control of protein folding by increasing clearance of misfolded proteins such as SGCE variants or holding them in an intermediate state for proper refolding. May have a redundant function with TOR1B in non-neural tissues.
Gene References into Functions
  1. TorsinA was post-transcriptionally upregulated upon acute ER stress, suggesting a role in this response. Increased basal phosphorylation of eIF2alpha in DYT1 transgenic rats was associated with abnormal response to acute ER stress. Unbiased RNA-Seq-based transcriptomic analysis of embryonic brain tissue in heterozygous and homozygous DYT1 knockin mice confirmed presence of eIF2alpha dysregulation in the DYT1 brain. PMID: 29289717
  2. Association between rs35153737 TOR1A variant and dystonia in a southwestern Chinese population. PMID: 28756192
  3. TOR1A exon 5 c.*302T>A is associated with isolated dystonia in southwestern Chinese. PMID: 28432771
  4. TOR1A variant found in sporadic focal dystonia impairs domains affected in DYT1 dystonia patients and animal models PMID: 27168150
  5. This study does not allow the establishment of genotype-specific clinical correlations for DYT1 in patient with isolated dystonia. PMID: 27477622
  6. This study show both MDYT1 and without clinical symptoms showed an abnormally enhanced Abnormal blink reflex recovery curve compared with the healthy controls. Moreover, the lack of a statistical difference between manifesting and nonmanifesting carriers suggests that their brainstem circuits are equivalently affected by the DYT1. gene PMID: 27508977
  7. A comparison of these structures shows, in atomic detail, the subtle differences in TorsinADeltaE-LULL1 activator interactions that separate the healthy from the diseased state. PMID: 27490483
  8. found that human Torsin1A and human FMRP were present in the same protein complexes, suggesting that this phenomenon is evolutionarily conserved PMID: 27313903
  9. The significant association of rs1182 and rs1801968 TOR1A variants was found in the development of focal dystonia and writer's cramp respectively. PMID: 28081261
  10. This study demonstrated that whole-exome sequencing show reveled TOR1A mutation with early-onset generalized dystonia. PMID: 27666935
  11. This study showed that the Phosphodiesterase-10A Inverse Changes in Striatopallidal and Striatoentopeduncular Pathways of a Transgenic Mouse Model of DYT1 Dystonia. PMID: 28115486
  12. Genetic screening targeted at currently known disease-causing mutations in TOR1A, THAP1, and TUBB4 appears to have low diagnostic yield in sporadic spasmodic dysphonia. In our cohort, only 2 patients tested positive for novel/rare variants in THAP1. PMID: 27188707
  13. there might not be an association between TOR1A or THAP1 and patients with adult-onset primary focal dystonia PMID: 26803725
  14. This processing occurs not only in stress-exposed cell lines but also in primary cells from distinct organisms including stimulated B cells, indicating that Torsin conversion in response to physiologically relevant stimuli is an evolutionarily conserved process. PMID: 26953341
  15. Our patient and three other reported carriers of non-c.907_909delGAG-mutations within the first three exons of TOR1A showed similar phenotypes of adult-onset focal or segmental cervical dystonia PMID: 26297380
  16. Plasma salusin-alpha and salusin-beta levels are increased in endometrioma patients and positively correlated with endometrioma size. PMID: 26008602
  17. the common rs2296793 and rs3842225 SNPs of TOR1A do not play a major role in cervical dystonia in a Chinese population. PMID: 26704435
  18. Certain TOR1A genotypes may be regarded as factors predisposing to focal and segmental dystonia. PMID: 25203860
  19. DYT1 mutations are associated with dystonia disorders PMID: 26596547
  20. TorA(DeltaE) in Drosophila brains may activate the UPR and increase the expression of HSP22 to compensate for the toxic effects PMID: 25903460
  21. The results of this study indicate that a loss of function of torsinA during cerebellar synaptogenesis induces important developmental alterations. PMID: 26183317
  22. Salusin-beta but not saluin-alpha is able to promote inflammatory responses in human umbilical vein endothelial cells. PMID: 25210730
  23. This review summarizes the current state of knowledge regarding the potential functions of torsin 1A in the context of hypothetical pathomechanisms responsible for torsion dystonia type 1. PMID: 26281352
  24. study reports 2 new, putative TOR1A mutations (p.A14_P15del and p.E121K)in dystonia patients that were examined functionally compared with wild-type and 2 known mutations (DeltaE and p.R288Q); findings demonstrate functional changes for all 4 mutations on different levels PMID: 24931141
  25. Data show that mutation of arginine 563 in lamina-associated polypeptide 1 (LAP1) reduces its ability to stimulate TorsinA PMID: 25149450
  26. DYT1 is caused by mutations of the TOR1A gene, located on 9q34, which causes dysfunction of the D1 direct pathway or the indirect pathway[review] PMID: 25192508
  27. These findings provide functional evidence for the potential pathogenic nature of these rare sequence variants in the TOR1A gene, thus implicating these pathologies in the development of dystonia. PMID: 24930953
  28. LAP1 and LULL1 regulate Torsin ATPase activity through an active site complementation mechanism. PMID: 25352667
  29. This study demonistrated that Combined occurrence of a novel TOR1A and a THAP1 mutation in primary dystonia. PMID: 24862462
  30. analysis for TOR1-A mutations should be performed only in patients with early onset, generalized, and familial dystonia. PMID: 25337725
  31. Primary dystonia in the Amish-Mennonites is genetically diverse and includes not only the THAP1 indel founder mutation but also different mutations in THAP1 and GNAL as well as the TOR1A GAG deletion. PMID: 24500857
  32. These results provide evidence for a regional specificity of the electrophysiological abnormalities observed and demonstrate the reproducibility of such alterations in distinct models of DYT1 dystonia. PMID: 24503369
  33. Data indicate that BiP (GRP78/Kar2) stabilizes torsinA and torsinADeltaE in mammalian cells. PMID: 24627482
  34. Current known dystonia genes include those related to dopamine metabolism, transcription factor, cytoskeleton, transport of glucose and sodium ion, etc. PMID: 23782819
  35. This study did not identify any significant association of 4 SNPs in the TOR1A gene in Dutch patients with torsion dystonia. PMID: 23460578
  36. The results of this study demonstrated a significantly higher frequency of H216 variant in PTD patients not carrying the DeltaGAG as compared with control subjects in Argentina. PMID: 23405979
  37. The results of this study suggested that genetic analysis for GAG deletion of DYT-1 gene may be performed even if dystonia starts at a very young age or it spreads to involve oromandibular muscles. PMID: 22770546
  38. In this study, we found that the rs1801968 variant of TOR1A was associated with early-onset primary dystonia . PMID: 23107556
  39. in dystonia DYT1 and DYT6 gene mutation carriers, diffusion tensor imaging detected fewer fibers in the cerebello-thalamo-cortical pathways PMID: 22987473
  40. No association of the rs1182 of TOR1A with Chinese primary dystonia was found. PMID: 23058565
  41. The DYT1 904-906 del GAG mutation is responsible for some of Iranian dystonia patients. PMID: 22487959
  42. variable clinical manifestation in different ethnic groups may suggest that ethnicity is a significant modifier of DYT1 dystonia PMID: 22622408
  43. In transgenic mice with DYT1 dystonia mutation stimulation of thalamostriatal axons triggered abnormal spiking activity in interneurons. PMID: 22933784
  44. The data of this study showed that the The GAG deletion in Tor1A (DYT1) is a rare cause of complex musician's dystonia. PMID: 22226333
  45. The results of this study did not support the hypothesis that common TOR1A variants affect susceptibility for sporadic primary dystonia. PMID: 22172551
  46. This study do not confirm that the allele contributes to the risk of D216H SNP primary dystonia. PMID: 22054283
  47. The DYT1 carrier state increases energy demand in the olivocerebellar network. PMID: 21241782
  48. The authors provide evidence that torsinA, a ubiquitously expressed ATPase, has a role in herpes simplex virus 1 nuclear egress. PMID: 21775450
  49. ER retention & membrane association are perturbed by a subset of nonconservative mutations to the N-terminal domain, suggesting that a helical structure with defined orientation in the membrane is required. PMID: 21785409
  50. Several genetic mutations have been identified that cause different forms of dystonia. [DYT1 gene -review article] PMID: 21636841

Show More

Hide All

Involvement in disease
Dystonia 1, torsion, autosomal dominant (DYT1)
Subcellular Location
Endoplasmic reticulum lumen. Nucleus membrane; Peripheral membrane protein. Cell projection, growth cone. Cytoplasmic vesicle membrane. Cytoplasmic vesicle, secretory vesicle. Cytoplasmic vesicle, secretory vesicle, synaptic vesicle. Cytoplasm, cytoskeleton.
Protein Families
ClpA/ClpB family, Torsin subfamily
Tissue Specificity
Widely expressed. Highest levels in kidney and liver. In the brain, high levels found in the dopaminergic neurons of the substantia nigra pars compacta, as well as in the neocortex, hippocampus and cerebellum. Also highly expressed in the spinal cord.
Database Links

HGNC: 3098

OMIM: 128100

KEGG: hsa:1861

STRING: 9606.ENSP00000345719

UniGene: Hs.534312

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
webinars: DT3C facilitates antibody internalization X